BOLKA PHARMACEUTICALS AIM
Bolka Pharmaceuticals (spin off company of Micar Innovation) is specialized in the discovery, development and commercialization of the small molecule drugs and transforming the treatment of chronic pain by advancing one of the largest, exclusively pain-focused clinical pipelines of novel, non-opioid therapies. By using structure based in silico drug design & AI (Micar21 platform) we constructed the best Chronic Pain drug candidate fast & validated.
We aim to bridge the safety and efficacy gaps in current approaches to chronic pain management. The company is focused on the development of the safe non-opioid-next-generation pain killer for the patients suffering from chronic pain, cancer pain, etc. Bolka Pharmaceuticals lead drug candidate, MIC4578, is currently in the phase preclinical for the treatment of chronic pain.
Type of organization: Company
Address: 38A, Karamfil street, 1616, Sofia, Bulgaria
Dimitar Dimitrov, Interim CEO & Co-Founder
Organzation: Bolka Pharmaceuticals